{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:58:01Z","timestamp":1790456281587,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K19293"],"award-info":[{"award-number":["JP25K19293"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00535-026-02486-2","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:27:28Z","timestamp":1785252448000},"page":"1450-1459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of 5-aminosalicylic acid intolerance on progression to difficult-to-treat ulcerative colitis: a retrospective cohort study"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3505-7835","authenticated-orcid":false,"given":"Masashi","family":"Ohno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Bamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Iwashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"2486_CR1","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jama.2023.15389","volume":"330","author":"B Gros","year":"2023","unstructured":"Gros B, Kaplan GG. Ulcerative colitis in adults: a review. JAMA. 2023;330:951\u201365.","journal-title":"JAMA"},{"key":"2486_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaf061","volume":"19","author":"J Bai","year":"2025","unstructured":"Bai J, Bouwknegt DG, Weersma RK, et al. Gene-environment interactions in inflammatory bowel disease: a systematic review of human epidemiologic studies. J Crohns Colitis. 2025;19:jjaf061.","journal-title":"J Crohns Colitis"},{"key":"2486_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Siegmund B, Le Berre C, et al. Ulcerative colitis. Nat Rev Dis Prim. 2020;6:74.","journal-title":"Nat Rev Dis Prim"},{"key":"2486_CR4","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1053\/j.gastro.2018.12.009","volume":"156","author":"CW Ko","year":"2019","unstructured":"Ko CW, Singh S, Feuerstein JD, et al. AGA clinical practice guidelines on the management of mild-to-moderate ulcerative colitis. Gastroenterology. 2019;156:748\u201364.","journal-title":"Gastroenterology"},{"key":"2486_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00535-021-01784-1","volume":"56","author":"H Nakase","year":"2020","unstructured":"Nakase H, Uchino M, Shinzaki S, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol. 2020;56:489\u2013526.","journal-title":"J Gastroenterol"},{"key":"2486_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","volume":"16","author":"T Raine","year":"2022","unstructured":"Raine T, Bonovas S, Burisch J, et al. ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J Crohns Colitis. 2022;16:2\u201317.","journal-title":"J Crohns Colitis"},{"key":"2486_CR7","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.14309\/ajg.0000000000003463","volume":"120","author":"DT Rubin","year":"2025","unstructured":"Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG clinical guideline update: ulcerative colitis in adults. Am J Gastroenterol. 2025;120:1187\u2013224.","journal-title":"Am J Gastroenterol"},{"key":"2486_CR8","volume":"8","author":"A Murray","year":"2020","unstructured":"Murray A, Nguyen TM, Parker CE, et al. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2020;8:CD000544.","journal-title":"Cochrane Database Syst Rev"},{"key":"2486_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/gut.28.5.613","volume":"28","author":"TK Chakraborty","year":"1987","unstructured":"Chakraborty TK, Bhatia D, Heading RC, et al. Salicylate induced exacerbation of ulcerative colitis. Gut. 1987;28:613\u20135.","journal-title":"Gut"},{"key":"2486_CR10","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/0016-5085(95)90154-X","volume":"108","author":"JB Sturgeon","year":"1995","unstructured":"Sturgeon JB, Bhatia P, Hermens D, et al. Exacerbation of chronic ulcerative colitis with mesalamine. Gastroenterology. 1995;108:1889\u201393.","journal-title":"Gastroenterology"},{"key":"2486_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.5217\/ir.2018.00015","volume":"16","author":"J Miyoshi","year":"2018","unstructured":"Miyoshi J, Matsuoka K, Yoshida A, et al. 5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis. Intest Res. 2018;16:635\u201340.","journal-title":"Intest Res"},{"key":"2486_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/jgh.15138","volume":"36","author":"S Hiraoka","year":"2021","unstructured":"Hiraoka S, Fujiwara A, Toyokawa T, et al. Multicenter survey on mesalamine intolerance in patients with ulcerative colitis. J Gastroenterol Hepatol. 2021;36:137\u201343.","journal-title":"J Gastroenterol Hepatol"},{"key":"2486_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000527452","volume":"104","author":"Y Mikami","year":"2023","unstructured":"Mikami Y, Tsunoda J, Suzuki S, et al. Significance of 5-aminosalicylic acid intolerance in the clinical management of ulcerative colitis. Digestion. 2023;104:58\u201365.","journal-title":"Digestion"},{"key":"2486_CR14","doi-asserted-by":"publisher","first-page":"pS801","DOI":"10.14309\/00000434-201710001-01464","volume":"112","author":"M Thomson","year":"2017","unstructured":"Thomson M, Kinnucan J. Mesalamine-induced Acute Intolerance Syndrome With Associated Mucosal Inflammation. Am J Gastroenterol. 2017;112:pS801.","journal-title":"Am J Gastroenterol"},{"key":"2486_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/apt.16120","volume":"53","author":"S Hibiya","year":"2021","unstructured":"Hibiya S, Matsuyama Y, Fujii T, et al. 5-aminosalicylate-intolerant patients are at increased risk of colectomy for ulcerative colitis. Aliment Pharmacol Ther. 2021;53:103\u201313.","journal-title":"Aliment Pharmacol Ther"},{"key":"2486_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5217\/ir.2019.00084","volume":"18","author":"S Mizuno","year":"2020","unstructured":"Mizuno S, Ono K, Mikami Y, et al. 5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis. Intest Res. 2020;18:69\u201378.","journal-title":"Intest Res"},{"key":"2486_CR17","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S2468-1253(23)00154-1","volume":"8","author":"TL Parigi","year":"2023","unstructured":"Parigi TL, D\u2019Amico F, Abreu MT, et al. Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting. Lancet Gastroenterol Hepatol. 2023;8:853\u20139.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2486_CR18","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.cgh.2013.05.017","volume":"12","author":"CP Selinger","year":"2014","unstructured":"Selinger CP, Andrews JM, Titman A, et al. Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014;12:644\u201350.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2486_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"2486_CR20","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00535-025-02279-z","volume":"60","author":"S Akiyama","year":"2025","unstructured":"Akiyama S, Ito Y, Shiroyama M, et al. Increasing age at diagnosis raises malignancy risk and aminosalicylate intolerance influences therapeutic strategies in ulcerative colitis: a multicenter I\u2011BRITE cohort study. J Gastroenterol. 2025;60:1259\u201371.","journal-title":"J Gastroenterol"},{"key":"2486_CR21","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.cgh.2024.01.003","volume":"22","author":"D Ahuja","year":"2024","unstructured":"Ahuja D, Luo J, Qi Y, et al. Imapct of treatment response on risk of serious infections in patients with Crohn\u2019s disease: secondary analysis of the PYRAMID Registry. Clin Gastroenterolo Hepatol. 2024;22:1286\u201394.","journal-title":"Clin Gastroenterolo Hepatol"},{"key":"2486_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae145","volume":"19","author":"TL Parigi","year":"2025","unstructured":"Parigi TL, Massimino L, Carini A, et al. Prevalence, characteristics, management, and outcomes of difficult-to-treat inflammatory bowel disease. J Crohns Colitis. 2025;19:jjae145.","journal-title":"J Crohns Colitis"},{"key":"2486_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185500","volume":"12","author":"N Pillai","year":"2017","unstructured":"Pillai N, Dusheiko M, Burnand B, et al. A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease. PLoS ONE. 2017;12:e0185500.","journal-title":"PLoS ONE"},{"key":"2486_CR24","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/medicina58040486","volume":"58","author":"T Stroie","year":"2022","unstructured":"Stroie T, Preda C, Meianu C, et al. Health-related quality of life in patients with inflammatory bowel disease in clinical remission: what should we look for? Medicina (Kaunas). 2022;58:486.","journal-title":"Medicina (Kaunas)"},{"key":"2486_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S2468-1253(21)00065-0","volume":"6","author":"D Alsoud","year":"2021","unstructured":"Alsoud D, Verstockt B, Fiocchi C, et al. Breaking the therapeutic ceiling in drug development in ulcerative colitis. Lancet Gastroenterol Hepatol. 2021;6:589\u201395.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2486_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5217\/ir.2024.00119","volume":"24","author":"K Matsuoka","year":"2026","unstructured":"Matsuoka K, Igarashi A, Sato N, et al. Clinical characteristics of patients with difficult-to-treat ulcerative colitis: a nested case-control study using a Japanese claims database. Intest Res. 2026;24:103\u201316.","journal-title":"Intest Res"},{"key":"2486_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8122109","volume":"8","author":"E Yasutomi","year":"2019","unstructured":"Yasutomi E, Hiraoka S, Yamamoto S, et al. Switching between three types of mesalazine formulation and sulfasalazine in patients with active ulcerative colitis who have already received high-dose treatment with these agents. J Clin Med. 2019;8:2109.","journal-title":"J Clin Med"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02486-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02486-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02486-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:02:08Z","timestamp":1790452928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-026-02486-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2486"],"URL":"https:\/\/doi.org\/10.1007\/s00535-026-02486-2","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}